Skip to content
Catalyst

PapersPMID:37657523

Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial.

The American journal of clinical nutrition2023The record ↗

  1. Finding, moderate evidencelowersBeck Depression Inventory (BDI) total score

What moved

1 findingHow to read these marks →
  • “Pairwise comparisons revealed BDI scores were significantly lower in the OF and OF/2’FL interventions compared with maltodextrin: OF (P ≤ 0.001; mean difference: −7.96; 95% CI: −12.03, −3.90); OF/2’FL (P ≤ 0.001; mean difference: −6.86; 95% CI: −10.93, −2.80).”
    Study
    RCT
    Duration
    4 weeks
    Effect
    −7.96 mean difference, 95% CI −12.03 to −3.9
    Dose studied
    oligofructose 8 g/d plus 2 g/d maltodextrin, once daily in water with breakfast
    Population
    Healthy adults aged 18 to 50 in the UK with mild-to-moderately elevated stress and anxiety; 4-week intervention; oligofructose arm (8 g/d plus 2 g/d maltodextrin) against maltodextrin 10 g/d, day-28 ANCOVA contrast

Study record

Design
randomised controlled trial
Species
human
Population
Healthy adults aged 18 to 50, Reading UK, with mild/moderately elevated stress and anxiety (PHQ-9 and GAD-7); inulin-type fructan tested is oligofructose (Orafti P95), alone and with 2'fucosyllactose, against maltodextrin
Participants
92
Comparator
placebo
Duration
28 days
Endpoints measured
102